LADENBURG THALMANN FINANCIAL SERVICES INC. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2019$80,000
+166.7%
1,348
+68.1%
0.00%
Q3 2019$30,000
-21.1%
802
-3.0%
0.00%
Q2 2019$38,000
+15.2%
8270.0%0.00%
Q1 2019$33,000
-31.2%
827
-21.0%
0.00%
Q4 2018$48,000
+336.4%
1,047
+349.4%
0.00%
Q3 2018$11,000
-85.1%
233
-77.0%
0.00%
-100.0%
Q2 2018$74,0000.0%1,0150.0%0.00%0.0%
Q1 2018$74,000
-26.7%
1,015
-33.4%
0.00%0.0%
Q4 2017$101,000
+27.8%
1,524
-2.6%
0.00%0.0%
Q3 2017$79,000
+61.2%
1,564
+49.0%
0.00%0.0%
Q2 2017$49,000
+58.1%
1,050
+18.5%
0.00%
Q1 2017$31,000
+181.8%
886
-1.6%
0.00%
Q4 2016$11,000
-8.3%
9000.0%0.00%
Q3 2016$12,000
+33.3%
9000.0%0.00%
Q2 2016$9,000
-40.0%
9000.0%0.00%
Q1 2016$15,000
-25.0%
9000.0%0.00%
Q4 2015$20,0009000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2019
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$22,344,00010.09%
Altium Capital Management LP 2,515,785$12,579,0003.47%
Deep Track Capital, LP 5,641,668$28,208,0001.99%
Paradigm Biocapital Advisors LP 839,257$4,196,0001.20%
SABBY MANAGEMENT, LLC 940,400$4,702,0000.68%
Monaco Asset Management SAM 500,000$2,500,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,000,000$25,000,0000.52%
CVI Holdings, LLC 1,460,595$7,303,0000.48%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$13,566,0000.38%
Rhenman & Partners Asset Management AB 1,000,000$4,960,0000.33%
View complete list of ESPERION THERAPEUTICS INC NE shareholders